Global Alzheimer’s Disease Therapeutics and Diagnostics Market Insights, Forecast to 2028

  • Report ID:244646
  • Industry Name: Medical Care
  • Publishing Date: Jun-22
  • No. of Pages: 87

Free Sample

Request Customization

Request A Callback

Enquiry before buying

 
                              

                               
Alzheimer’s Disease Therapeutics and Diagnostics market is segmented by players, region (country), by Type and by Application. Players, stakeholders, and other participants in the global Alzheimer’s Disease Therapeutics and Diagnostics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application for the period 2017-2028.
Segment by Type
    Diagnostics
    Treatment
Segment by Application
    Marketed Drugs
    Pipeline Drugs
By Company
    Pfizer
    Eisai
    Novartis
    Forest Laboratories
    TauRx Therapeutics
    AC Immune
    Johnson & Johnson.
    H. Lundbeck
By Region
    North America
        United States
        Canada
    Europe
        Germany
        France
        UK
        Italy
        Russia
        Nordic Countries
        Rest of Europe
    Asia-Pacific
        China
        Japan
        South Korea
        Southeast Asia
        India
        Australia
        Rest of Asia
    Latin America
        Mexico
        Brazil
        Rest of Latin America
    Middle East & Africa
        Turkey
        Saudi Arabia
        UAE
        Rest of MEA
                           

                       
                        

                         
1 Report Business Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Alzheimer’s Disease Therapeutics and Diagnostics Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
        1.2.2 Diagnostics
        1.2.3 Treatment
    1.3 Market by Application
        1.3.1 Global Alzheimer’s Disease Therapeutics and Diagnostics Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
        1.3.2 Marketed Drugs
        1.3.3 Pipeline Drugs
    1.4 Study Objectives
    1.5 Years Considered
2 Global Growth Trends
    2.1 Global Alzheimer’s Disease Therapeutics and Diagnostics Market Perspective (2017-2028)
    2.2 Alzheimer’s Disease Therapeutics and Diagnostics Growth Trends by Region
        2.2.1 Alzheimer’s Disease Therapeutics and Diagnostics Market Size by Region: 2017 VS 2021 VS 2028
        2.2.2 Alzheimer’s Disease Therapeutics and Diagnostics Historic Market Size by Region (2017-2022)
        2.2.3 Alzheimer’s Disease Therapeutics and Diagnostics Forecasted Market Size by Region (2023-2028)
    2.3 Alzheimer’s Disease Therapeutics and Diagnostics Market Dynamics
        2.3.1 Alzheimer’s Disease Therapeutics and Diagnostics Industry Trends
        2.3.2 Alzheimer’s Disease Therapeutics and Diagnostics Market Drivers
        2.3.3 Alzheimer’s Disease Therapeutics and Diagnostics Market Challenges
        2.3.4 Alzheimer’s Disease Therapeutics and Diagnostics Market Restraints
3 Competition Landscape by Key Players
    3.1 Global Top Alzheimer’s Disease Therapeutics and Diagnostics Players by Revenue
        3.1.1 Global Top Alzheimer’s Disease Therapeutics and Diagnostics Players by Revenue (2017-2022)
        3.1.2 Global Alzheimer’s Disease Therapeutics and Diagnostics Revenue Market Share by Players (2017-2022)
    3.2 Global Alzheimer’s Disease Therapeutics and Diagnostics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    3.3 Players Covered: Ranking by Alzheimer’s Disease Therapeutics and Diagnostics Revenue
    3.4 Global Alzheimer’s Disease Therapeutics and Diagnostics Market Concentration Ratio
        3.4.1 Global Alzheimer’s Disease Therapeutics and Diagnostics Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Alzheimer’s Disease Therapeutics and Diagnostics Revenue in 2021
    3.5 Alzheimer’s Disease Therapeutics and Diagnostics Key Players Head office and Area Served
    3.6 Key Players Alzheimer’s Disease Therapeutics and Diagnostics Product Solution and Service
    3.7 Date of Enter into Alzheimer’s Disease Therapeutics and Diagnostics Market
    3.8 Mergers & Acquisitions, Expansion Plans
4 Alzheimer’s Disease Therapeutics and Diagnostics Breakdown Data by Type
    4.1 Global Alzheimer’s Disease Therapeutics and Diagnostics Historic Market Size by Type (2017-2022)
    4.2 Global Alzheimer’s Disease Therapeutics and Diagnostics Forecasted Market Size by Type (2023-2028)
5 Alzheimer’s Disease Therapeutics and Diagnostics Breakdown Data by Application
    5.1 Global Alzheimer’s Disease Therapeutics and Diagnostics Historic Market Size by Application (2017-2022)
    5.2 Global Alzheimer’s Disease Therapeutics and Diagnostics Forecasted Market Size by Application (2023-2028)
6 North America
    6.1 North America Alzheimer’s Disease Therapeutics and Diagnostics Market Size (2017-2028)
    6.2 North America Alzheimer’s Disease Therapeutics and Diagnostics Market Size by Type
        6.2.1 North America Alzheimer’s Disease Therapeutics and Diagnostics Market Size by Type (2017-2022)
        6.2.2 North America Alzheimer’s Disease Therapeutics and Diagnostics Market Size by Type (2023-2028)
        6.2.3 North America Alzheimer’s Disease Therapeutics and Diagnostics Market Share by Type (2017-2028)
    6.3 North America Alzheimer’s Disease Therapeutics and Diagnostics Market Size by Application
        6.3.1 North America Alzheimer’s Disease Therapeutics and Diagnostics Market Size by Application (2017-2022)
        6.3.2 North America Alzheimer’s Disease Therapeutics and Diagnostics Market Size by Application (2023-2028)
        6.3.3 North America Alzheimer’s Disease Therapeutics and Diagnostics Market Share by Application (2017-2028)
    6.4 North America Alzheimer’s Disease Therapeutics and Diagnostics Market Size by Country
        6.4.1 North America Alzheimer’s Disease Therapeutics and Diagnostics Market Size by Country (2017-2022)
        6.4.2 North America Alzheimer’s Disease Therapeutics and Diagnostics Market Size by Country (2023-2028)
        6.4.3 U.S.
        6.4.4 Canada
7 Europe
    7.1 Europe Alzheimer’s Disease Therapeutics and Diagnostics Market Size (2017-2028)
    7.2 Europe Alzheimer’s Disease Therapeutics and Diagnostics Market Size by Type
        7.2.1 Europe Alzheimer’s Disease Therapeutics and Diagnostics Market Size by Type (2017-2022)
        7.2.2 Europe Alzheimer’s Disease Therapeutics and Diagnostics Market Size by Type (2023-2028)
        7.2.3 Europe Alzheimer’s Disease Therapeutics and Diagnostics Market Share by Type (2017-2028)
    7.3 Europe Alzheimer’s Disease Therapeutics and Diagnostics Market Size by Application
        7.3.1 Europe Alzheimer’s Disease Therapeutics and Diagnostics Market Size by Application (2017-2022)
        7.3.2 Europe Alzheimer’s Disease Therapeutics and Diagnostics Market Size by Application (2023-2028)
        7.3.3 Europe Alzheimer’s Disease Therapeutics and Diagnostics Market Share by Application (2017-2028)
    7.4 Europe Alzheimer’s Disease Therapeutics and Diagnostics Market Size by Country
        7.4.1 Europe Alzheimer’s Disease Therapeutics and Diagnostics Market Size by Country (2017-2022)
        7.4.2 Europe Alzheimer’s Disease Therapeutics and Diagnostics Market Size by Country (2023-2028)
        7.4.3 Germany
        7.4.4 France
        7.4.5 U.K.
        7.4.6 Italy
        7.4.7 Russia
        7.4.8 Nordic Countries
8 Asia-Pacific
    8.1 Asia-Pacific Alzheimer’s Disease Therapeutics and Diagnostics Market Size (2017-2028)
    8.2 Asia-Pacific Alzheimer’s Disease Therapeutics and Diagnostics Market Size by Type
        8.2.1 Asia-Pacific Alzheimer’s Disease Therapeutics and Diagnostics Market Size by Type (2017-2022)
        8.2.2 Asia-Pacific Alzheimer’s Disease Therapeutics and Diagnostics Market Size by Type (2023-2028)
        8.2.3 Asia-Pacific Alzheimer’s Disease Therapeutics and Diagnostics Market Share by Type (2017-2028)
    8.3 Asia-Pacific Alzheimer’s Disease Therapeutics and Diagnostics Market Size by Application
        8.3.1 Asia-Pacific Alzheimer’s Disease Therapeutics and Diagnostics Market Size by Application (2017-2022)
        8.3.2 Asia-Pacific Alzheimer’s Disease Therapeutics and Diagnostics Market Size by Application (2023-2028)
        8.3.3 Asia-Pacific Alzheimer’s Disease Therapeutics and Diagnostics Market Share by Application (2017-2028)
    8.4 Asia-Pacific Alzheimer’s Disease Therapeutics and Diagnostics Market Size by Region
        8.4.1 Asia-Pacific Alzheimer’s Disease Therapeutics and Diagnostics Market Size by Region (2017-2022)
        8.4.2 Asia-Pacific Alzheimer’s Disease Therapeutics and Diagnostics Market Size by Region (2023-2028)
        8.4.3 China
        8.4.4 Japan
        8.4.5 South Korea
        8.4.6 Southeast Asia
        8.4.7 India
        8.4.8 Australia 
9 Latin America
    9.1 Latin America Alzheimer’s Disease Therapeutics and Diagnostics Market Size (2017-2028)
    9.2 Latin America Alzheimer’s Disease Therapeutics and Diagnostics Market Size by Type
        9.2.1 Latin America Alzheimer’s Disease Therapeutics and Diagnostics Market Size by Type (2017-2022)
        9.2.2 Latin America Alzheimer’s Disease Therapeutics and Diagnostics Market Size by Type (2023-2028)
        9.2.3 Latin America Alzheimer’s Disease Therapeutics and Diagnostics Market Share by Type (2017-2028)
    9.3 Latin America Alzheimer’s Disease Therapeutics and Diagnostics Market Size by Application
        9.3.1 Latin America Alzheimer’s Disease Therapeutics and Diagnostics Market Size by Application (2017-2022)
        9.3.2 Latin America Alzheimer’s Disease Therapeutics and Diagnostics Market Size by Application (2023-2028)
        9.3.3 Latin America Alzheimer’s Disease Therapeutics and Diagnostics Market Share by Application (2017-2028)
    9.4 Latin America Alzheimer’s Disease Therapeutics and Diagnostics Market Size by Country
        9.4.1 Latin America Alzheimer’s Disease Therapeutics and Diagnostics Market Size by Country (2017-2022)
        9.4.2 Latin America Alzheimer’s Disease Therapeutics and Diagnostics Market Size by Country (2023-2028)
        9.4.3 Mexico
        9.4.4 Brazil
10 Middle East & Africa
    10.1 Middle East & Africa Alzheimer’s Disease Therapeutics and Diagnostics Market Size (2017-2028)
    10.2 Middle East & Africa Alzheimer’s Disease Therapeutics and Diagnostics Market Size by Type
        10.2.1 Middle East & Africa Alzheimer’s Disease Therapeutics and Diagnostics Market Size by Type (2017-2022)
        10.2.2 Middle East & Africa Alzheimer’s Disease Therapeutics and Diagnostics Market Size by Type (2023-2028)
        10.2.3 Middle East & Africa Alzheimer’s Disease Therapeutics and Diagnostics Market Share by Type (2017-2028)
    10.3 Middle East & Africa Alzheimer’s Disease Therapeutics and Diagnostics Market Size by Application
        10.3.1 Middle East & Africa Alzheimer’s Disease Therapeutics and Diagnostics Market Size by Application (2017-2022)
        10.3.2 Middle East & Africa Alzheimer’s Disease Therapeutics and Diagnostics Market Size by Application (2023-2028)
        10.3.3 Middle East & Africa Alzheimer’s Disease Therapeutics and Diagnostics Market Share by Application (2017-2028)
    10.4 Middle East & Africa Alzheimer’s Disease Therapeutics and Diagnostics Market Size by Country
        10.4.1 Middle East & Africa Alzheimer’s Disease Therapeutics and Diagnostics Market Size by Country (2017-2022)
        10.4.2 Middle East & Africa Alzheimer’s Disease Therapeutics and Diagnostics Market Size by Country (2023-2028)
        10.4.3 Turkey
        10.4.4 Saudi Arabia
        10.4.5 UAE
11 Key Players Profiles
    11.1 Pfizer
        11.1.1 Pfizer Company Details
        11.1.2 Pfizer Business Overview
        11.1.3 Pfizer Alzheimer’s Disease Therapeutics and Diagnostics Introduction
        11.1.4 Pfizer Revenue in Alzheimer’s Disease Therapeutics and Diagnostics Business (2017-2022)
        11.1.5 Pfizer Recent Developments
    11.2 Eisai
        11.2.1 Eisai Company Details
        11.2.2 Eisai Business Overview
        11.2.3 Eisai Alzheimer’s Disease Therapeutics and Diagnostics Introduction
        11.2.4 Eisai Revenue in Alzheimer’s Disease Therapeutics and Diagnostics Business (2017-2022)
        11.2.5 Eisai Recent Developments
    11.3 Novartis
        11.3.1 Novartis Company Details
        11.3.2 Novartis Business Overview
        11.3.3 Novartis Alzheimer’s Disease Therapeutics and Diagnostics Introduction
        11.3.4 Novartis Revenue in Alzheimer’s Disease Therapeutics and Diagnostics Business (2017-2022)
        11.3.5 Novartis Recent Developments
    11.4 Forest Laboratories
        11.4.1 Forest Laboratories Company Details
        11.4.2 Forest Laboratories Business Overview
        11.4.3 Forest Laboratories Alzheimer’s Disease Therapeutics and Diagnostics Introduction
        11.4.4 Forest Laboratories Revenue in Alzheimer’s Disease Therapeutics and Diagnostics Business (2017-2022)
        11.4.5 Forest Laboratories Recent Developments
    11.5 TauRx Therapeutics
        11.5.1 TauRx Therapeutics Company Details
        11.5.2 TauRx Therapeutics Business Overview
        11.5.3 TauRx Therapeutics Alzheimer’s Disease Therapeutics and Diagnostics Introduction
        11.5.4 TauRx Therapeutics Revenue in Alzheimer’s Disease Therapeutics and Diagnostics Business (2017-2022)
        11.5.5 TauRx Therapeutics Recent Developments
    11.6 AC Immune
        11.6.1 AC Immune Company Details
        11.6.2 AC Immune Business Overview
        11.6.3 AC Immune Alzheimer’s Disease Therapeutics and Diagnostics Introduction
        11.6.4 AC Immune Revenue in Alzheimer’s Disease Therapeutics and Diagnostics Business (2017-2022)
        11.6.5 AC Immune Recent Developments
    11.7 Johnson & Johnson.
        11.7.1 Johnson & Johnson. Company Details
        11.7.2 Johnson & Johnson. Business Overview
        11.7.3 Johnson & Johnson. Alzheimer’s Disease Therapeutics and Diagnostics Introduction
        11.7.4 Johnson & Johnson. Revenue in Alzheimer’s Disease Therapeutics and Diagnostics Business (2017-2022)
        11.7.5 Johnson & Johnson. Recent Developments
    11.8 H. Lundbeck
        11.8.1 H. Lundbeck Company Details
        11.8.2 H. Lundbeck Business Overview
        11.8.3 H. Lundbeck Alzheimer’s Disease Therapeutics and Diagnostics Introduction
        11.8.4 H. Lundbeck Revenue in Alzheimer’s Disease Therapeutics and Diagnostics Business (2017-2022)
        11.8.5 H. Lundbeck Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Author Details
    13.3 Disclaimer
Read More 
                

                 
List of Tables
    Table 1. Global Alzheimer’s Disease Therapeutics and Diagnostics Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028
    Table 2. Key Players of Diagnostics
    Table 3. Key Players of Treatment
    Table 4. Global Alzheimer’s Disease Therapeutics and Diagnostics Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028
    Table 5. Global Alzheimer’s Disease Therapeutics and Diagnostics Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
    Table 6. Global Alzheimer’s Disease Therapeutics and Diagnostics Market Size by Region (2017-2022) & (US$ Million)
    Table 7. Global Alzheimer’s Disease Therapeutics and Diagnostics Market Share by Region (2017-2022)
    Table 8. Global Alzheimer’s Disease Therapeutics and Diagnostics Forecasted Market Size by Region (2023-2028) & (US$ Million)
    Table 9. Global Alzheimer’s Disease Therapeutics and Diagnostics Market Share by Region (2023-2028)
    Table 10. Alzheimer’s Disease Therapeutics and Diagnostics Market Trends
    Table 11. Alzheimer’s Disease Therapeutics and Diagnostics Market Drivers
    Table 12. Alzheimer’s Disease Therapeutics and Diagnostics Market Challenges
    Table 13. Alzheimer’s Disease Therapeutics and Diagnostics Market Restraints
    Table 14. Global Alzheimer’s Disease Therapeutics and Diagnostics Revenue by Players (2017-2022) & (US$ Million)
    Table 15. Global Alzheimer’s Disease Therapeutics and Diagnostics Revenue Share by Players (2017-2022)
    Table 16. Global Top Alzheimer’s Disease Therapeutics and Diagnostics by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Alzheimer’s Disease Therapeutics and Diagnostics as of 2021)
    Table 17. Ranking of Global Top Alzheimer’s Disease Therapeutics and Diagnostics Companies by Revenue (US$ Million) in 2021
    Table 18. Global 5 Largest Players Market Share by Alzheimer’s Disease Therapeutics and Diagnostics Revenue (CR5 and HHI) & (2017-2022)
    Table 19. Key Players Headquarters and Area Served
    Table 20. Key Players Alzheimer’s Disease Therapeutics and Diagnostics Product Solution and Service
    Table 21. Date of Enter into Alzheimer’s Disease Therapeutics and Diagnostics Market
    Table 22. Mergers & Acquisitions, Expansion Plans
    Table 23. Global Alzheimer’s Disease Therapeutics and Diagnostics Market Size by Type (2017-2022) & (US$ Million)
    Table 24. Global Alzheimer’s Disease Therapeutics and Diagnostics Revenue Market Share by Type (2017-2022)
    Table 25. Global Alzheimer’s Disease Therapeutics and Diagnostics Forecasted Market Size by Type (2023-2028) & (US$ Million)
    Table 26. Global Alzheimer’s Disease Therapeutics and Diagnostics Revenue Market Share by Type (2023-2028)
    Table 27. Global Alzheimer’s Disease Therapeutics and Diagnostics Market Size by Application (2017-2022) & (US$ Million)
    Table 28. Global Alzheimer’s Disease Therapeutics and Diagnostics Revenue Share by Application (2017-2022)
    Table 29. Global Alzheimer’s Disease Therapeutics and Diagnostics Forecasted Market Size by Application (2023-2028) & (US$ Million)
    Table 30. Global Alzheimer’s Disease Therapeutics and Diagnostics Revenue Share by Application (2023-2028)
    Table 31. North America Alzheimer’s Disease Therapeutics and Diagnostics Market Size by Type (2017-2022) & (US$ Million)
    Table 32. North America Alzheimer’s Disease Therapeutics and Diagnostics Market Size by Type (2023-2028) & (US$ Million)
    Table 33. North America Alzheimer’s Disease Therapeutics and Diagnostics Market Size by Application (2017-2022) & (US$ Million)
    Table 34. North America Alzheimer’s Disease Therapeutics and Diagnostics Market Size by Application (2023-2028) & (US$ Million)
    Table 35. North America Alzheimer’s Disease Therapeutics and Diagnostics Market Size by Country (2017-2022) & (US$ Million)
    Table 36. North America Alzheimer’s Disease Therapeutics and Diagnostics Market Size by Country (2023-2028) & (US$ Million)
    Table 37. Europe Alzheimer’s Disease Therapeutics and Diagnostics Market Size by Type (2017-2022) & (US$ Million)
    Table 38. Europe Alzheimer’s Disease Therapeutics and Diagnostics Market Size by Type (2023-2028) & (US$ Million)
    Table 39. Europe Alzheimer’s Disease Therapeutics and Diagnostics Market Size by Application (2017-2022) & (US$ Million)
    Table 40. Europe Alzheimer’s Disease Therapeutics and Diagnostics Market Size by Application (2023-2028) & (US$ Million)
    Table 41. Europe Alzheimer’s Disease Therapeutics and Diagnostics Market Size by Country (2017-2022) & (US$ Million)
    Table 42. Europe Alzheimer’s Disease Therapeutics and Diagnostics Market Size by Country (2023-2028) & (US$ Million)
    Table 43. Asia Pacific Alzheimer’s Disease Therapeutics and Diagnostics Market Size by Type (2017-2022) & (US$ Million)
    Table 44. Asia Pacific Alzheimer’s Disease Therapeutics and Diagnostics Market Size by Type (2023-2028) & (US$ Million)
    Table 45. Asia Pacific Alzheimer’s Disease Therapeutics and Diagnostics Market Size by Application (2017-2022) & (US$ Million)
    Table 46. Asia Pacific Alzheimer’s Disease Therapeutics and Diagnostics Market Size by Application (2023-2028) & (US$ Million)
    Table 47. Asia Pacific Alzheimer’s Disease Therapeutics and Diagnostics Market Size by Region (2017-2022) & (US$ Million)
    Table 48. Asia Pacific Alzheimer’s Disease Therapeutics and Diagnostics Market Size by Region (2023-2028) & (US$ Million)
    Table 49. Latin America Alzheimer’s Disease Therapeutics and Diagnostics Market Size by Type (2017-2022) & (US$ Million)
    Table 50. Latin America Alzheimer’s Disease Therapeutics and Diagnostics Market Size by Type (2023-2028) & (US$ Million)
    Table 51. Latin America Alzheimer’s Disease Therapeutics and Diagnostics Market Size by Application (2017-2022) & (US$ Million)
    Table 52. Latin America Alzheimer’s Disease Therapeutics and Diagnostics Market Size by Application (2023-2028) & (US$ Million)
    Table 53. Latin America Alzheimer’s Disease Therapeutics and Diagnostics Market Size by Country (2017-2022) & (US$ Million)
    Table 54. Latin America Alzheimer’s Disease Therapeutics and Diagnostics Market Size by Country (2023-2028) & (US$ Million)
    Table 55. Middle East and Africa Alzheimer’s Disease Therapeutics and Diagnostics Market Size by Type (2017-2022) & (US$ Million)
    Table 56. Middle East and Africa Alzheimer’s Disease Therapeutics and Diagnostics Market Size by Type (2023-2028) & (US$ Million)
    Table 57. Middle East and Africa Alzheimer’s Disease Therapeutics and Diagnostics Market Size by Application (2017-2022) & (US$ Million)
    Table 58. Middle East and Africa Alzheimer’s Disease Therapeutics and Diagnostics Market Size by Application (2023-2028) & (US$ Million)
    Table 59. Middle East and Africa Alzheimer’s Disease Therapeutics and Diagnostics Market Size by Country (2017-2022) & (US$ Million)
    Table 60. Middle East and Africa Alzheimer’s Disease Therapeutics and Diagnostics Market Size by Country (2023-2028) & (US$ Million)
    Table 61. Pfizer Company Details
    Table 62. Pfizer Business Overview
    Table 63. Pfizer Alzheimer’s Disease Therapeutics and Diagnostics Product
    Table 64. Pfizer Revenue in Alzheimer’s Disease Therapeutics and Diagnostics Business (2017-2022) & (US$ Million)
    Table 65. Pfizer Recent Developments
    Table 66. Eisai Company Details
    Table 67. Eisai Business Overview
    Table 68. Eisai Alzheimer’s Disease Therapeutics and Diagnostics Product
    Table 69. Eisai Revenue in Alzheimer’s Disease Therapeutics and Diagnostics Business (2017-2022) & (US$ Million)
    Table 70. Eisai Recent Developments
    Table 71. Novartis Company Details
    Table 72. Novartis Business Overview
    Table 73. Novartis Alzheimer’s Disease Therapeutics and Diagnostics Product
    Table 74. Novartis Revenue in Alzheimer’s Disease Therapeutics and Diagnostics Business (2017-2022) & (US$ Million)
    Table 75. Novartis Recent Developments
    Table 76. Forest Laboratories Company Details
    Table 77. Forest Laboratories Business Overview
    Table 78. Forest Laboratories Alzheimer’s Disease Therapeutics and Diagnostics Product
    Table 79. Forest Laboratories Revenue in Alzheimer’s Disease Therapeutics and Diagnostics Business (2017-2022) & (US$ Million)
    Table 80. Forest Laboratories Recent Developments
    Table 81. TauRx Therapeutics Company Details
    Table 82. TauRx Therapeutics Business Overview
    Table 83. TauRx Therapeutics Alzheimer’s Disease Therapeutics and Diagnostics Product
    Table 84. TauRx Therapeutics Revenue in Alzheimer’s Disease Therapeutics and Diagnostics Business (2017-2022) & (US$ Million)
    Table 85. TauRx Therapeutics Recent Developments
    Table 86. AC Immune Company Details
    Table 87. AC Immune Business Overview
    Table 88. AC Immune Alzheimer’s Disease Therapeutics and Diagnostics Product
    Table 89. AC Immune Revenue in Alzheimer’s Disease Therapeutics and Diagnostics Business (2017-2022) & (US$ Million)
    Table 90. AC Immune Recent Developments
    Table 91. Johnson & Johnson. Company Details
    Table 92. Johnson & Johnson. Business Overview
    Table 93. Johnson & Johnson. Alzheimer’s Disease Therapeutics and Diagnostics Product
    Table 94. Johnson & Johnson. Revenue in Alzheimer’s Disease Therapeutics and Diagnostics Business (2017-2022) & (US$ Million)
    Table 95. Johnson & Johnson. Recent Developments
    Table 96. H. Lundbeck Company Details
    Table 97. H. Lundbeck Business Overview
    Table 98. H. Lundbeck Alzheimer’s Disease Therapeutics and Diagnostics Product
    Table 99. H. Lundbeck Revenue in Alzheimer’s Disease Therapeutics and Diagnostics Business (2017-2022) & (US$ Million)
    Table 100. H. Lundbeck Recent Developments
    Table 101. Research Programs/Design for This Report
    Table 102. Key Data Information from Secondary Sources
    Table 103. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Alzheimer’s Disease Therapeutics and Diagnostics Market Share by Type: 2021 VS 2028
    Figure 2. Diagnostics Features
    Figure 3. Treatment Features
    Figure 4. Global Alzheimer’s Disease Therapeutics and Diagnostics Market Share by Application: 2021 VS 2028
    Figure 5. Marketed Drugs Case Studies
    Figure 6. Pipeline Drugs Case Studies
    Figure 7. Alzheimer’s Disease Therapeutics and Diagnostics Report Years Considered
    Figure 8. Global Alzheimer’s Disease Therapeutics and Diagnostics Market Size (US$ Million), Year-over-Year: 2017-2028
    Figure 9. Global Alzheimer’s Disease Therapeutics and Diagnostics Market Size, (US$ Million), 2017 VS 2021 VS 2028
    Figure 10. Global Alzheimer’s Disease Therapeutics and Diagnostics Market Share by Region: 2021 VS 2028
    Figure 11. Global Alzheimer’s Disease Therapeutics and Diagnostics Market Share by Players in 2021
    Figure 12. Global Top Alzheimer’s Disease Therapeutics and Diagnostics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Alzheimer’s Disease Therapeutics and Diagnostics as of 2021)
    Figure 13. The Top 10 and 5 Players Market Share by Alzheimer’s Disease Therapeutics and Diagnostics Revenue in 2021
    Figure 14. North America Alzheimer’s Disease Therapeutics and Diagnostics Market Size YoY (2017-2028) & (US$ Million)
    Figure 15. North America Alzheimer’s Disease Therapeutics and Diagnostics Market Size Market Share by Type (2017-2028)
    Figure 16. North America Alzheimer’s Disease Therapeutics and Diagnostics Market Size Market Share by Application (2017-2028)
    Figure 17. North America Alzheimer’s Disease Therapeutics and Diagnostics Market Size Share by Country (2017-2028)
    Figure 18. United States Alzheimer’s Disease Therapeutics and Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 19. Canada Alzheimer’s Disease Therapeutics and Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 20. Europe Alzheimer’s Disease Therapeutics and Diagnostics Market Size YoY (2017-2028) & (US$ Million)
    Figure 21. Europe Alzheimer’s Disease Therapeutics and Diagnostics Market Size Market Share by Type (2017-2028)
    Figure 22. Europe Alzheimer’s Disease Therapeutics and Diagnostics Market Size Market Share by Application (2017-2028)
    Figure 23. Europe Alzheimer’s Disease Therapeutics and Diagnostics Market Size Share by Country (2017-2028)
    Figure 24. Germany Alzheimer’s Disease Therapeutics and Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 25. France Alzheimer’s Disease Therapeutics and Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 26. U.K. Alzheimer’s Disease Therapeutics and Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 27. Italy Alzheimer’s Disease Therapeutics and Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 28. Russia Alzheimer’s Disease Therapeutics and Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 29. Nordic Countries Alzheimer’s Disease Therapeutics and Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 30. Asia-Pacific Alzheimer’s Disease Therapeutics and Diagnostics Market Size YoY (2017-2028) & (US$ Million)
    Figure 31. Asia Pacific Alzheimer’s Disease Therapeutics and Diagnostics Market Size Market Share by Type (2017-2028)
    Figure 32. Asia Pacific Alzheimer’s Disease Therapeutics and Diagnostics Market Size Market Share by Application (2017-2028)
    Figure 33. Asia Pacific Alzheimer’s Disease Therapeutics and Diagnostics Market Size Share by Region (2017-2028)
    Figure 34. China Alzheimer’s Disease Therapeutics and Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 35. Japan Alzheimer’s Disease Therapeutics and Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 36. South Korea Alzheimer’s Disease Therapeutics and Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 37. Southeast Asia Alzheimer’s Disease Therapeutics and Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 38. India Alzheimer’s Disease Therapeutics and Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 39. Australia Alzheimer’s Disease Therapeutics and Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
List of Figures
    Figure 40. Latin America Alzheimer’s Disease Therapeutics and Diagnostics Market Size YoY (2017-2028) & (US$ Million)
    Figure 41. Latin America Alzheimer’s Disease Therapeutics and Diagnostics Market Size Market Share by Type (2017-2028)
    Figure 42. Latin America Alzheimer’s Disease Therapeutics and Diagnostics Market Size Market Share by Application (2017-2028)
    Figure 43. Latin America Alzheimer’s Disease Therapeutics and Diagnostics Market Size Share by Country (2017-2028)
    Figure 44. Mexico Alzheimer’s Disease Therapeutics and Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 45. Brazil Alzheimer’s Disease Therapeutics and Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 46. Middle East & Africa Alzheimer’s Disease Therapeutics and Diagnostics Market Size YoY (2017-2028) & (US$ Million)
    Figure 47. Middle East and Africa Alzheimer’s Disease Therapeutics and Diagnostics Market Size Market Share by Type (2017-2028)
    Figure 48. Middle East and Africa Alzheimer’s Disease Therapeutics and Diagnostics Market Size Market Share by Application (2017-2028)
    Figure 49. Middle East and Africa Alzheimer’s Disease Therapeutics and Diagnostics Market Size Share by Country (2017-2028)
    Figure 50. Turkey Alzheimer’s Disease Therapeutics and Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 51. Saudi Arabia Alzheimer’s Disease Therapeutics and Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 52. UAE Alzheimer’s Disease Therapeutics and Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 53. Pfizer Revenue Growth Rate in Alzheimer’s Disease Therapeutics and Diagnostics Business (2017-2022)
    Figure 54. Eisai Revenue Growth Rate in Alzheimer’s Disease Therapeutics and Diagnostics Business (2017-2022)
    Figure 55. Novartis Revenue Growth Rate in Alzheimer’s Disease Therapeutics and Diagnostics Business (2017-2022)
    Figure 56. Forest Laboratories Revenue Growth Rate in Alzheimer’s Disease Therapeutics and Diagnostics Business (2017-2022)
    Figure 57. TauRx Therapeutics Revenue Growth Rate in Alzheimer’s Disease Therapeutics and Diagnostics Business (2017-2022)
    Figure 58. AC Immune Revenue Growth Rate in Alzheimer’s Disease Therapeutics and Diagnostics Business (2017-2022)
    Figure 59. Johnson & Johnson. Revenue Growth Rate in Alzheimer’s Disease Therapeutics and Diagnostics Business (2017-2022)
    Figure 60. H. Lundbeck Revenue Growth Rate in Alzheimer’s Disease Therapeutics and Diagnostics Business (2017-2022)
    Figure 61. Bottom-up and Top-down Approaches for This Report
    Figure 62. Data Triangulation
    Figure 63. Key Executives Interviewed

Purchase Report

Single User 3480
Multi User 5250
Corporate User 6960
Buy

Speak To Analyst

Purchase Report

Customize the purchase as per your specific research needs:

  • 20% additional customization
  • Request for country level reports
  • Request for historical statistics
  • Additional company profile on request

Why Choose Our Report?

24/5 Research support

Get your queries resolved from an industry expert

Custom research service

Design an exclusive study to serve your research needs.

Information security

Your personal and confidential information is safe and secure.

Related Reports

Global Frontotemporal Disorders Treatment Market Insights and Forecast to 2028
  • Report ID:209953
  • Industry Name: Medical Care
  • Publishing Date: Jun-22
  • No. of Pages: 87
  • 3480

Global Backend-as-a-Service Market 2021 by Company, Regions, Type and Application, Foreca...
  • Report ID:40702
  • Industry Name: Medical Care
  • Publishing Date: Jun-22
  • No. of Pages: 87
  • 3480

Global Temperature Controlled Packaging Solution for Pharmaceutical Market Insights and F...
  • Report ID:211388
  • Industry Name: Medical Care
  • Publishing Date: Jun-22
  • No. of Pages: 87
  • 3480

Global Healthcare Revenue Cycle Management (RCM) Market 2021 by Company, Regions, Type an...
  • Report ID:41150
  • Industry Name: Medical Care
  • Publishing Date: Jun-22
  • No. of Pages: 87
  • 3480

Global Relapsing-Remitting Multiple Sclerosis Market Research Report 2022
  • Report ID:213970
  • Industry Name: Medical Care
  • Publishing Date: Jun-22
  • No. of Pages: 87
  • 2900

clock

+1  347 708 0418

clocksales@acorinsights.com

trusted-site ssl paypal

COPYRIGHT © 2021 Acor Insights | All Rights Reserved.